CH418340A - Verfahren zur Herstellung eines neuen Derivats des 1,3-Diazacyclopentens - Google Patents

Verfahren zur Herstellung eines neuen Derivats des 1,3-Diazacyclopentens

Info

Publication number
CH418340A
CH418340A CH1351962A CH1351962A CH418340A CH 418340 A CH418340 A CH 418340A CH 1351962 A CH1351962 A CH 1351962A CH 1351962 A CH1351962 A CH 1351962A CH 418340 A CH418340 A CH 418340A
Authority
CH
Switzerland
Prior art keywords
diazacyclopentene
preparation
new derivative
derivative
new
Prior art date
Application number
CH1351962A
Other languages
English (en)
Inventor
Karl Zeile
Karl-Heinz Hauptmann
Helmut Staehle
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CH418340A publication Critical patent/CH418340A/de

Links

Classifications

    • H—ELECTRICITY
    • H03—ELECTRONIC CIRCUITRY
    • H03G—CONTROL OF AMPLIFICATION
    • H03G1/00—Details of arrangements for controlling amplification
    • H03G1/0005—Circuits characterised by the type of controlling devices operated by a controlling current or voltage signal
    • H03G1/0017—Circuits characterised by the type of controlling devices operated by a controlling current or voltage signal the device being at least one of the amplifying solid-state elements
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q9/00—Preparations for removing hair or for aiding hair removal
    • A61Q9/02—Shaving preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CH1351962A 1961-11-30 1962-11-19 Verfahren zur Herstellung eines neuen Derivats des 1,3-Diazacyclopentens CH418340A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB64998A DE1154119B (de) 1961-11-30 1961-11-30 Verfahren zur Herstellung von 2-(2', 4', 6'-Trimethylbenzyl)-1, 3-diazacyclopenten-(2) und seinen Salzen

Publications (1)

Publication Number Publication Date
CH418340A true CH418340A (de) 1966-08-15

Family

ID=6974599

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1351962A CH418340A (de) 1961-11-30 1962-11-19 Verfahren zur Herstellung eines neuen Derivats des 1,3-Diazacyclopentens

Country Status (8)

Country Link
US (1) US3300511A (de)
CH (1) CH418340A (de)
DE (1) DE1154119B (de)
FI (1) FI42565C (de)
FR (1) FR1506256A (de)
GB (1) GB965621A (de)
NL (1) NL286080A (de)
SE (1) SE219203C1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2008089B (en) * 1977-08-26 1982-06-09 Wellcome Found Imidazole derivatives and salts thereof their synthesis and intermediates and pharmaceutical formulations
EP0086428B1 (de) * 1979-08-23 1987-07-29 Beecham Group Plc Veterinärmittel gegen Diarrhöe, seine Herstellung und dieses enthaltende orale Dosierungsvorrichtung
US5969137A (en) * 1996-09-19 1999-10-19 Virginia Commonwealth University Benzylamidine derivatives with serotonin receptor binding activity
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
WO2002005853A2 (en) * 2000-07-14 2002-01-24 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20040214829A1 (en) * 2000-07-14 2004-10-28 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
HU230383B1 (hu) * 2000-07-14 2016-03-29 Allergan, Inc Oldékonyságfokozó komponens használata brimodinin-tartarátot tartalmazó vizes készítményekben

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868802A (en) * 1959-01-13 Nxchj
US2161938A (en) * 1934-07-31 1939-06-13 Soc Of Chemical Ind Imidazolines

Also Published As

Publication number Publication date
FI42565C (fi) 1970-09-14
SE219203C1 (sv) 1968-02-27
FR1506256A (fr) 1967-12-22
DE1154119B (de) 1963-09-12
GB965621A (en) 1964-08-06
FI42565B (de) 1970-06-01
US3300511A (en) 1967-01-24
NL286080A (nl) 1965-02-10

Similar Documents

Publication Publication Date Title
AT267494B (de) Verfahren zur Herstellung des neuen 1-Isocyanato-3-isocyanatomethyl-3,5,5-trimethylcyclohexans
AT238716B (de) Verfahren zur Herstellung von neuen Derivaten des 7-Oxycumarins
AT238720B (de) Verfahren zur Herstellung von neuen 6,11-Dihydro-dibenz(b,e)-thiepin-Derivaten
CH418340A (de) Verfahren zur Herstellung eines neuen Derivats des 1,3-Diazacyclopentens
AT212830B (de) Verfahren zur Herstellung neuer 1,2,4-Oxdiazole
CH413848A (de) Verfahren zur Herstellung eines neuen Imidazolinderivates
CH376114A (de) Verfahren zur Herstellung eines substituierten 2,6-Diketo-piperazins
AT249885B (de) Verfahren zur Herstellung eines neuen Hexapeptids
AT241467B (de) Verfahren zur Herstellung von neuen 1, 4-Bis {[chlorchinolyl-(4')]-aminoalkyl }-piperazinen
CH372059A (de) Verfahren zur Herstellung von neuen 3,5-Diketopyrazolidinen
CH464946A (de) Verfahren zur Herstellung von neuen Derivaten des 6-Methyl-und 1,6-Dimethyl-ergolins II
AT257059B (de) Verfahren zur Herstellung von neuen 6, 16α-Dialkyl-17α-hydroxy-progesteronen
CH407118A (de) Verfahren zur Herstellung eines neuen Piperidinderivates
AT250572B (de) Verfahren zur Herstellung von neuen Heptapeptidderivaten
CH400142A (de) Verfahren zur Herstellung neuer 3,3-Difluor-androstane
CH385202A (de) Verfahren zur Herstellung des neuen 4,11B-Dihydroxy-17a-methyltestosterons
CH408012A (de) Verfahren zur Herstellung eines neuen Harnstoffes
AT253147B (de) Verfahren zur Herstellung eines neuen Nonadekapeptids
AT249019B (de) Verfahren zur Herstellung des neuen 3-Brom-3-chlor-1,1,2,2-tetrafluorpropan
CH432537A (de) Verfahren zur Herstellung von neuen Derivaten des 6-Methyl- und 1,6-Dimethylergolins II
AT260431B (de) Verfahren zur Herstellung des neuen 1,2,3-Trimethoxy-9-cyan-10-oxo-5,6,7,8,9,10,11,12-octahydrobenzo-(a)-heptalens
AT199190B (de) Verfahren zur Herstellung der neuen Dihydro-m-thiazine-Δ-3,4
AT196878B (de) Verfahren zur Herstellung einer neuen Additionsverbindung des 4,6-Dimethyl-2-hydroxypyrimidins
AT201058B (de) Verfahren zur Herstellung von neuen 3,5-Diketopyrazolidinderivaten
AT242133B (de) Verfahren zur Herstellung des neuen N-Β-Hydroxyäthylcarbazolthiodipropionats